Back to VVUS Stock Lookup

VVUS Related Corporate News

May 16, 2013 07:04 AM VIVUS (VVUS) Prices $220M Convertible Debt Offering

May 15, 2013 07:07 AM VIVUS (VVUS) Launches $200M Convertible Notes Offering

May 13, 2013 07:08 AM VIVUS (VVUS) CEO Wilson Issues Shareholder Letter; Plans on Broader Qsiva Expansion

May 7, 2013 04:42 PM First Manhattan Files Presentation on VIVUS (VVUS) Board

May 3, 2013 09:20 AM VIVUS (VVUS) to Report Q1 Results May 8th; Focus on Promotions vs. New Rx

Apr 26, 2013 09:26 AM VIVUS, Inc. (VVUS) Avanafil Receives Positive CHMP Opinion

Apr 22, 2013 08:32 AM VIVUS (VVUS) Plans to Present at Four Conferences Through End of May

Apr 19, 2013 06:10 AM VIVUS (VVUS) March Qsymia Shipments Rose 29%

Apr 16, 2013 02:31 PM VIVUS, Inc. (VVUS) Qsymia Receives FDA Approval for REMS Modification

Apr 16, 2013 06:21 AM First Manhattan Requests VIVUS (VVUS) Review Board Nominees

Mar 26, 2013 06:31 AM VIVUS (VVUS) Enters $110M non-Equity Financing Agreement; Will Draw $50M Initially

Mar 8, 2013 03:16 PM VIVUS, Inc. (VVUS) Affirms Receipt of Nomination from First Manhattan

Mar 5, 2013 07:01 AM VIVUS, Inc. (VVUS) Debuts New Save Now! Program for Qsymia

Mar 4, 2013 06:46 AM VIVUS (VVUS) Schedules Three Presentations for March 2013

Feb 25, 2013 08:35 AM VIVUS (VVUS) Enters Third Amedement with Mitsubishi Tanabe Pharma

Feb 21, 2013 05:01 PM EMA CHMP Declines VIVUS (VVUS) MAA for Qsiva

Feb 1, 2013 07:15 AM VIVUS (VVUS) Reports Publication of Signifianct Data from Recent Qsymia Study

Jan 7, 2013 06:45 AM VIVUS (VVUS) Qsymia Prescriptions Jump 140%+ After Free Trial Program Starts

Dec 20, 2012 06:31 AM VIVUS (VVUS) Says Qsymia Now Covered by Express Scripts' (ESRX)

Dec 17, 2012 04:18 PM VIVUS (VVUS) Enters New Lease in Mountain View, CA

Nov 26, 2012 08:34 AM VIVUS, Inc. (VVUS) Begins Qsymia Free Trial Offer Program (CVS) (WAG)

Nov 12, 2012 07:03 AM Vivus (VVUS) Announces Significant Data from Obstructive Sleep Apnea Trial

Oct 18, 2012 05:31 PM VIVUS (VVUS) Formally Denied MAA for Qsiva by CHMP; Cites Concern Over Cadio, Nervous System Effects

Oct 17, 2012 07:04 AM VIVUS (VVUS) Submits Amdendment to REMS for Qsymia to Expand Distribution

Oct 8, 2012 07:01 AM Express Scripts (ESRX) Becomes Part of Qsymia Home Delivery Network (VVUS)

Oct 3, 2012 06:56 AM VIVUS (VVUS) Securities Fraud Lawsuit Dismissed

Oct 3, 2012 06:51 AM Vivus (VVUS) to Make Several Qsymia Presentations at 48th EASD

Sep 21, 2012 07:05 AM VIVUS (VVUS) Says EMA CHMP May Recommend Against MAA for Qsiva

Sep 18, 2012 07:02 AM VIVUS (VVUS) Says Qsymia Weight-Loss Pill Available in U.S. Market

Jul 18, 2012 09:08 AM VIVUS' (VVUS) Qsymia Approved and has Advantages Over Belviq

Jul 17, 2012 07:20 PM FDA Approves VIVUS (VVUS) Weight-Management Drug Qsymia

Jun 27, 2012 04:17 PM Arena (ARNA) Gets FDA Ok for Potential Blockbuster Fat Pill

Jun 5, 2012 06:47 AM VIVUS (VVUS) Says EMA CHMP Reschedules Qnexa MAA Decision Process for Sept. '12

May 10, 2012 08:28 AM With Arena Pharmaceuticals (ARNA) Halted Ahead of AdCom, There Will Be Other Ways to Play...

Apr 27, 2012 03:46 PM VIVUS (VVUS) Confirms FDA Approval of Stendra Tablets

Apr 27, 2012 02:10 PM FDA Approves VIVUS's (VVUS) Stendra (avanafil) for Erectile Dysfunction

Apr 27, 2012 01:00 PM VIVUS's (VVUS) Avanafil has won approval -Bloomberg

Apr 9, 2012 04:46 PM FDA Extends PDUFA Date for VIVUS's (VVUS) Qnexa NDA to July 17th

Mar 29, 2012 03:38 PM FDA Panel Votes 17-6 Obesity Drugmakers Should Study Heart Risks; Watch Orexigen (OREX, VIVUS (VVUS), Arena (ARNA)

Mar 27, 2012 06:48 AM VIVUS (VVUS) Expands Management Team Ahead of Expected Qnexa Approval

Mar 26, 2012 06:46 AM VIVUS (VVUS) Gets EMA Acceptance of Avanafil Marketing App

Feb 22, 2012 05:43 PM VIVUS (VVUS) Confirms FDA Panel Recommends Approval of Qnexa for Obesity

Feb 22, 2012 02:56 PM FDA Panel Discussing VIVUS's (VVUS) Qnexa...

Feb 17, 2012 08:06 AM FDA Briefing Documents for VIVUS's (VVUS) Qnexa Released

Jan 17, 2012 07:06 AM VIVUS (VVUS) Announces REVIVE Trial Results for Avanafil

Jan 9, 2012 06:47 AM FDA Asks VIVUS (VVUS) to Adjust Contraindicting Qnexa Label for Pregnant Women

Dec 23, 2011 06:47 AM VIVUS (VVUS) Gets Target Data for Qnexa NDA Review by FDA Committee

Dec 21, 2011 04:01 PM VIVUS (VVUS) Reports Topline Results from OC Data from Topiramate Exposure

Dec 8, 2011 08:09 AM VIVUS (VVUS) Reports Publication of Encouraging Qnexa Data in Cardiometabolic Disease Patients

Dec 7, 2011 06:52 AM VIVUS (VVUS) Reports Encouraging Data from CONQUER for QNEXA in Obese Diabetes Patients

Back to VVUS Stock Lookup